Natriuretic peptides, extracellular volume, and subclinical cardiovascular changes in chronic kidney disease stages 1–3: a pilot study

L Parker Gregg, Peter N Van Buren, David J Ramsey, Amaris Maydon, Subhash Banerjee, Carl P Walther, Salim S Virani, Wolfgang C Winkelmayer, Sankar D Navaneethan, S Susan Hedayati
DOI: 10.1136/jim-2022-002467 Published 19 July 2022
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

No eLetters have been published for this article.
Back to top
Email
Print
Alerts
Citation Tools
Cite This
Download PDF

Natriuretic peptides, extracellular volume, and subclinical cardiovascular changes in chronic kidney disease stages 1–3: a pilot study
L Parker Gregg, Peter N Van Buren, David J Ramsey, Amaris Maydon, Subhash Banerjee, Carl P Walther, Salim S Virani, Wolfgang C Winkelmayer, Sankar D Navaneethan, S Susan Hedayati
Journal of Investigative Medicine Jul 2022, jim-2022-002467; DOI: 10.1136/jim-2022-002467
Reddit logo Twitter logo Facebook logo Mendeley logo